Has Christine Liaw, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,281 in general payments to Christine Liaw, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christine Liaw, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christine Liaw, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christine Liaw, MD

Urology · Bridgeport, CTNPI 1144684648

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 90.1% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $15,616, more than ten times the $446 reported in 2021. Among urology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,281in general payments, 2019–2025

Across 78 payments — averaging $349.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$25K
Teleflex LLC$856
EDAP Technomed Inc$375
Procept Biorobotics Corporation$333
Urogen Pharma, Inc.$301
Astellas Pharma Global Development$252
plus $579 from 6 others

What the payments were for

Consulting fees$11,60043%
Speaking & faculty fees$8,55031%
Travel & lodging$2,4199%
Food & beverage$4,70717%
Education$50%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	47	$24,585
Teleflex LLC	10	$856
EDAP Technomed Inc	3	$375
Procept Biorobotics Corporation	2	$333
Urogen Pharma, Inc.	3	$301
Astellas Pharma Global Development	2	$252
Axonics, Inc.	3	$240
Calyxo, Inc.	1	$111
Johnson & Johnson	3	$78
Ferring Pharmaceuticals Inc.	1	$75
Endo USA, Inc.	2	$53
Coloplast	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL BPH$8,764
GENERAL KIDNEY STONE DISEASE$5,620
Lumenis Pulse 120H$1,836
UroLift$800
AQUABEAM SYSTEM$333
JELMYTO$296
XTANDI$252
Axonics$212
Tria Firm$143
EMS SWISS LITHOCLAST TRIOLOGY$122
CVAC Aspiration System$111

How this compares

$27,281 in reported general payments places this provider in the 90th percentile of 156 urology providers in Connecticut.

See all urology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$119,194

Medicare patients

229

Services billed

1,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	59	$44,451
Tamsulosin Hcl	225	$1,947
Potassium Citrate ErPotassium Citrate	13	$1,361
Finasteride	37	$566
Oxybutynin Chloride ErOxybutynin Chloride	45	$559
Tadalafil	12	$367
Dutasteride	15	$220
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	18	$190
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	63	$141
Ciprofloxacin Hcl	27	$119
Alfuzosin Hcl ErAlfuzosin Hcl	14	$118
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	19	$100

Paid to pharmacies, not to this prescriber.

Other urology in Bridgeport

Jeffrey SmallBridgeport$6K
Daniel KellnerNew Haven$122K
Gerard PregenzerEnfield$92K
Mary SoysterTorrington$58K
Preston SprenkleNew Haven$57K
Grace BiggsDerby$52K
Stanton HonigNew Haven$40K
Joshua SteinNew Britain$30K
Steven ShichmanHartford$28K
David CrawleyNew London$25K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →